Skip to main content

Advertisement

SpringerLink
Log in

Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer

  • Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Objective

Breast cancer is the most common cancer and the main cause of cancer morbidity for women worldwide and is manifestation of abnormal genetic as well as epigenetic changes. Therefore, our aim was to study the association of BRCA1 promoter methylation with rs11655505 (c.−2265C/T) variants and gene expression in sporadic breast cancer.

Methods

Twenty-nine sporadic breast cancer tissues and 26 normal biopsies were used for this study. Genomic DNA and total RNA were extracted from paraffin-embedded tissue and SNP analysis performed. Methylation status of the BRCA1 promoter region was determined by methylation-specific PCR after sodium bisulfite modification of DNA.

Results

Among all clinical–pathological parameters only estrogen receptor –ve and +ve samples were significantly different for methylation status (P = 0.04). The genotypic (CC, CT and TT), allelic frequencies and methylation status had not been found to be significantly different from that of healthy controls (P = 0.67, 0.71 and 0.17, respectively). Similarly, methylated BRCA1 promoter was not found to be significantly different in different genotypes from unmethylated promoters between patients and controls. Interestingly, only heterozygous (CT) genotypes with low and normal expression of BRCA1 were significantly different for the differential expression of BRCA1 compared to controls (P = 0.004). However, in tumor samples decreased expression of gene is associated with methylated state of BRCA1 promoter [OR (95 % CI) = 25.09 (2.17–29.75); P = 0.01].

Conclusions

Our data suggest that both single nucleotide variations rs11655505 (c.–2265C/T) and the methylation status of BRCA1 are not associated significantly with the occurrence of sporadic breast cancer in studied population. However, decreased expression of gene is associated with the CT genotypes and the disease. But, in case of tumor samples, an association of methylation of the promoter to the decreased expression of BRCA1 gene suggests the possible role of methylation in gene silencing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Alshatwi AA, Hasan TN, Shafi G et al (2012) Breast J 18(4):383–385. doi:10.1111/j.1524-4741.2012.01260.x

    Google Scholar 

  2. Parkin DM, Nambooze S, Wabwire-Mangen F, Wabinga HR (2010) Changing cancer incidence in Kampala, Uganda, 1991–2006. Int J Cancer 126:1187–1195

    PubMed  CAS  Google Scholar 

  3. Parkin DM, Whelan S, Ferlay J, Storm H (eds) (2005) Cancer incidence in five continents, vol I–VIII. Cancer Base No. 7. IARC Press, Lyon

  4. Bin Amer SM, Maqbool Z, Nirmal MS et al (2008) Gene expression profiling in women with breast cancer in Saudi population. Saudi Med J 29:507–513

    PubMed  Google Scholar 

  5. Murthy NS, Chaudhry K, Nadayil D, Agarwal UK, Saxena S (2009) Changing trends in incidence of breast cancer: Indian scenario. Indian J Cancer 46:73–74

    Article  PubMed  CAS  Google Scholar 

  6. Indian Council of Medical Research (2002) National Cancer Registry Programme of India—an overview. NCRP, Bangalore

    Google Scholar 

  7. Couch FJ, DeShano ML, Blackwood MA et al (1997) BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336:1409–1415

    Article  PubMed  CAS  Google Scholar 

  8. King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643–646

    Article  PubMed  CAS  Google Scholar 

  9. Fackenthal JD, Olopade OI (2007) Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer 7:937–948

    Article  PubMed  CAS  Google Scholar 

  10. Matros E, Wang ZC, Lodeiro G, Miron A, Iglehart JD, Richardson AL (2005) BRCA1 promoter methylation in sporadic breast tumours: relationship to gene expression profiles. Breast Cancer Res Treat 91:179–186

    Article  PubMed  CAS  Google Scholar 

  11. Rice JC, Ozcelik H, Maxeiner P, Andrulis I, Futscher BW (2000) Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis 21:1761–1765

    Article  PubMed  CAS  Google Scholar 

  12. Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT (1995) Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 9:444–450

    Article  PubMed  CAS  Google Scholar 

  13. Catteau A, Morris JR (2002) BRCA1 methylation: a significant role in tumour development? Semin Cancer Biol 12:359–371

    Article  PubMed  CAS  Google Scholar 

  14. Esteller M, Fraga MF, Guo M et al (2001) DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet 10:3001–3007

    Article  PubMed  CAS  Google Scholar 

  15. Hedenfalk I, Duggan D, Chen Y et al (2001) Gene-expression profiles in hereditary breast cancer. N Engl J Med 344:539–548

    Article  PubMed  CAS  Google Scholar 

  16. van’t Veer LJ, Dai H, van de Vijver MJ et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530–536

    Article  Google Scholar 

  17. Yu C, Zhou Y, Miao X, Xiong P, Tan W, Lin D (2004) Functional haplotypes in the promoter of matrix metalloproteinase-2 predicts risk of the occurrence and metastasis of esophageal cancer. Cancer Res 64:7622–7628

    Article  PubMed  CAS  Google Scholar 

  18. Freedman ML, Penney KL, Stram DO et al (2005) A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk. Cancer Res 65:7516–7522

    Article  PubMed  CAS  Google Scholar 

  19. Verderio P, Pizzamiglio S, Southey MC et al (2010) A BRCA1 promoter variant (rs11655505) and breast cancer risk. J Med Genet 47:268–270

    Article  PubMed  CAS  Google Scholar 

  20. Chan KY, Liu W, Long JR et al (2009) Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women. J Med Genet 46:32–39

    Article  PubMed  CAS  Google Scholar 

  21. Alshatwi AA, Hasan TN, Shafi G, Alsaif MA, Al-Hazzani AA, Alsaif AA (2011) A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population. Fundam Clin Pharmacol. doi:10.1111/j.1472-8206.2011.00939.x

    PubMed  Google Scholar 

  22. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821–9826

    Article  PubMed  CAS  Google Scholar 

  23. Baldwin RL, Nemeth E, Tran H et al (2000) BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study. Cancer Res 60:5329–5333

    PubMed  CAS  Google Scholar 

  24. Wei M, Grushko TA, Dignam J et al (2005) BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. Cancer Res 65:10692–10699

    Article  PubMed  CAS  Google Scholar 

  25. Futreal PA, Liu Q, Shattuck-Eidens D et al (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120–122

    Article  PubMed  CAS  Google Scholar 

  26. Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042–2054

    Article  PubMed  CAS  Google Scholar 

  27. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415–428

    Article  PubMed  CAS  Google Scholar 

  28. Birgisdottir V, Stefansson OA, Bodvarsdottir SK, Hilmarsdottir H, Jonasson JG, Eyfjord JE (2006) Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Breast Cancer Res 8:R38

    Article  PubMed  Google Scholar 

  29. Bosviel R, Garcia S, Lavediaux G et al (2012) BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls. Cancer Epidemiol 36(3):e177–182

    Google Scholar 

  30. Wong EM, Southey MC, Fox SB et al (2011) Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer. Cancer Prev Res (Phila) 4:23–33

    Article  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. R&D Center, Bharathiar University, Coimbatore, 641046, Tamil Nadu, India

    Tarique N. Hasan

  2. Department of Biotechnology, Vinayaka Missions University, Salem, Tamil Nadu, India

    B. Leena Grace

  3. Department of Molecular Biology, Institute of Genetics and Hospital for Genetic Diseases, Hyderabad, India

    Gowhar Shafi

  4. Department of Genetics, Mahavir Hospital and Research Center, Hyderabad, India

    Rabbani Syed

Authors
  1. Tarique N. Hasan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Leena Grace
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gowhar Shafi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rabbani Syed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tarique N. Hasan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hasan, T.N., Leena Grace, B., Shafi, G. et al. Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer. Clin Transl Oncol 15, 555–562 (2013). https://doi.org/10.1007/s12094-012-0968-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-012-0968-y

Keywords

Search

Navigation